Literature DB >> 11447760

Retinoblastoma protein partners.

E J Morris1, N J Dyson.   

Abstract

Studies of the retinoblastoma gene (Rb) have shown that its protein product (pRb) acts to restrict cell proliferation, inhibit apoptosis, and promote cell differentiation. The frequent mutation of the Rb gene, and the functional inactivation of pRb in tumor cells, have spurred interest in the mechanism of pRb action. Recently, much attention has focused on pRb's role in the regulation of the E2F transcription factor. However, biochemical studies have suggested that E2F is only one of many pRb-targets and, to date, at least 110 cellular proteins have been reported to associate with pRb. The plethora of pRb-binding proteins raises several important questions. How many functions does pRb possess, which of these functions are important for development, and which contribute to tumor suppression? The goal of this review is to summarize the current literature of pRb-associated proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447760     DOI: 10.1016/s0065-230x(01)82001-7

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  137 in total

1.  Clefts, grooves, and (small) pockets: the structure of the retinoblastoma tumor suppressor in complex with its cellular target E2F unveiled.

Authors:  Karl Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

Review 2.  Human retinoblastoma binding protein 9, a serine hydrolase implicated in pancreatic cancers.

Authors:  Sergey M Vorobiev; Yuanpeng Janet Huang; Jayaraman Seetharaman; Rong Xiao; Thomas B Acton; Gaetano T Montelione; Liang Tong
Journal:  Protein Pept Lett       Date:  2012-02       Impact factor: 1.890

3.  Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage.

Authors:  E J Morris; E Keramaris; H J Rideout; R S Slack; N J Dyson; L Stefanis; D S Park
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  [Prognostic significance of immunohistochemical studies].

Authors:  M Montenarh
Journal:  HNO       Date:  2003-10       Impact factor: 1.284

5.  Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development.

Authors:  Kerry L Ferguson; Jacqueline L Vanderluit; Jean M Hébert; W C McIntosh; Emma Tibbo; Jason G MacLaurin; David S Park; Valerie A Wallace; Marc Vooijs; Susan K McConnell; Ruth S Slack
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

6.  RB reversibly inhibits DNA replication via two temporally distinct mechanisms.

Authors:  Steven P Angus; Christopher N Mayhew; David A Solomon; Wesley A Braden; Michael P Markey; Yukiko Okuno; M Cristina Cardoso; David M Gilbert; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  Phosphorylation puts the pRb tumor suppressor into shape.

Authors:  Andreas M F Heilmann; Nicholas J Dyson
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

8.  Computational modeling of signaling pathways mediating cell cycle checkpoint control and apoptotic responses to ionizing radiation-induced DNA damage.

Authors:  Yuchao Zhao; In Chio Lou; Rory B Conolly
Journal:  Dose Response       Date:  2011-10-25       Impact factor: 2.658

9.  Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.

Authors:  Eriko Suzuki; Yue Zhao; Saya Ito; Shun Sawatsubashi; Takuya Murata; Takashi Furutani; Yuko Shirode; Kaoru Yamagata; Masahiko Tanabe; Shuhei Kimura; Takashi Ueda; Sally Fujiyama; Jinseon Lim; Hiroyuki Matsukawa; Alexander P Kouzmenko; Toshiro Aigaki; Tetsuya Tabata; Ken-ichi Takeyama; Shigeaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  Loss of RBF1 changes glutamine catabolism.

Authors:  Brandon N Nicolay; Paulo A Gameiro; Katrin Tschöp; Michael Korenjak; Andreas M Heilmann; John M Asara; Gregory Stephanopoulos; Othon Iliopoulos; Nicholas J Dyson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.